ARTICLE | Clinical News
Miravant preclinical data
March 26, 2001 8:00 AM UTC
MRVT said that in hypercholesterolemic rabbits, its MV6401 selectively localized in atherosclerotic plaques. Intravascular light treatment then gave a site-specific reduction in plaque cells. Results ...